Looking ahead to the MDRT CEO Forum Singapore 2027, MDRT remains committed to strengthening its suite of member resources and ...

Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, today announced that Basecamp Research, a frontier AI lab for therapeutic design, has selected the UG200 Series as the ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Xponential Fitness Inc. (NYSE: XPOF) resulting from ...

On March 19, 2026, a supplement was filed notifying shareholders of the Vest 2 Year Interest Rate Hedge ETF (HYKE) and the Vest 10 Year Interest Rate Hedge ETF (RYSE) respectively (each, a "Fund" and ...

Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Gemini Space Station, Inc. ("Gemini" or the "Company") (NasdaqGS: GEMI ...

First Trust Advisors L.P. ("FTA") is a federally registered investment advisor and serves as the Fund's investment advisor. FTA and its affiliate First Trust Portfolios L.P. ("FTP"), a FINRA ...

TRACE ASI has announced the launch of its advanced artificial intelligence-powered market analysis platform designed to help ...

Bltz AI introduces a new category of self-healing, agentic AI security that automatically prevents and fixes risks in real time, transforming AI security from reactive detection into a continuous, ...

Institute for Supply Management ® (ISM ®) announced the winners of its 2025 ISM ® 30 Under 30 Rising Supply Chain Stars Recognition Program, honoring 30 exceptional young professionals who are making ...

AirX Climate Solutions, Inc. ("ACS"), a leading independent full-service specialty HVAC solutions provider, announced today that it has acquired Northern Air Systems, Inc. ("Northern Air"), a premier ...

Record full year 2025 net sales of $32.0, an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increa ...

Positive 12-month Phase 2 data for NDV-01 in non-muscle invasive bladder cancer (NMIBC) demonstrated a 95% complete response (CR) rate at any time and a durable 76% CR rate at 12 months, with ...